𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer

✍ Scribed by Nima Sharifi; Akinobu Hamada; Tristan Sissung; Romano Danesi; David Venzon; Caitlin Baum; James L. Gulley; Douglas K. Price; William L. Dahut; William D. Figg

Book ID
109054008
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
168 KB
Volume
102
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Androgen receptor: A key molecule in the
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
✍ Mary-Ellen Taplin; Steven P. Balk πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 2 views

## Abstract Despite earlier detection and recent advances in surgery and radiation, prostate cancer is second only to lung cancer in male cancer deaths in the United States. Hormone therapy in the form of medical or surgical castration remains the mainstay of systemic treatment in prostate cancer.

TENB2, a proteoglycan identified in pros
TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence
✍ Eveline Glynne-Jones; Maureen E. Harper; Liam T. Seery; Rhianedd James; Ian Angl πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 258 KB

TENB2 encodes a putative transmembrane proteoglycan, related to the EGF/heregulin family of growth factors and follistatin, which has been identified through the application of a differential display technique to a xenograft model of prostate cancer. Northern analysis and competitive PCR were used t